Zhu Bin, Zheng Feng, Liu Ning, Zhu Ming-Hui, Xie Jun, Ye Ji-Ru, Zhang Jun, Jiang Dan-Qian, Yang Chun, Jiang Yong
Department of Critical Care Medicine, Third Affiliated Hospital of Soochow University, Changzhou, China (mainland).
Department of Pathology, Third Affiliated Hospital of Soochow University, Changzhou, China (mainland).
Med Sci Monit. 2014 Sep 26;20:1728-34. doi: 10.12659/MSM.891272.
The complexity of multiple-item criteria in acute respiratory distress syndrome (ARDS) often causes inconvenience for physicians in the management of patients with severe acute pancreatitis (SAP). We evaluated whether serum SP-A levels in the presence of diffuse alveolar damage (DAD) can be qualitatively assessed for diagnosis of SAP-induced ARDS.
Eighty rats were randomly divided into 2 groups (n=40 each) - the sham-operated (SO) group and the SAP group - and then randomly subdivided into 4 subgroups in a time-course manner. Furthermore, rats in the SAP group were subdivided into the SAP induced-ARDS group (ARDS group) and the SAP without ARDS group (non-ARDS group) according to the diagnostic standard of ARDS. The diagnostic cut-off values of SP-A for SAP-induced ARDS were determined by the receiver operating characteristic curve (ROC).
Serum SP-A levels in Baseline, SO group, SAP group, ARDS group, and non-ARDS group were 43.15±14.29, 51.91±16.99, 193.4±35.37, 198.0+29.73, and 185.7±43.21 ug/ml, respectively. The best cut-off value for the serum SP-A level for the diagnosis of SAP-induced ARDS was 150 ug/ml and the area under the ROC curve of SP-A was 0.88. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of SP-A in the diagnosis of SAP-induced ARDS were 100.0%, 81.8%, 71.4%, 100.0%, and 87.5%, respectively.
Serum SP-A levels may allow the detection of SAP-induced ARDS and may help to support the clinical diagnosis of ARDS. The optimal serum SP-A cut-off value to discriminate SAP-induced ARDS and other groups (SO group and non-ARDS group) is around 150 ug/ml.
急性呼吸窘迫综合征(ARDS)多项标准的复杂性常常给医生管理重症急性胰腺炎(SAP)患者带来不便。我们评估了在存在弥漫性肺泡损伤(DAD)的情况下,血清表面活性蛋白A(SP-A)水平能否用于定性评估SAP诱发的ARDS。
80只大鼠随机分为2组(每组n = 40)——假手术(SO)组和SAP组,然后按时间进程随机再分为4个亚组。此外,根据ARDS的诊断标准,将SAP组大鼠分为SAP诱发的ARDS组(ARDS组)和无ARDS的SAP组(非ARDS组)。通过受试者操作特征曲线(ROC)确定SP-A对SAP诱发的ARDS的诊断临界值。
基线时、SO组、SAP组、ARDS组和非ARDS组的血清SP-A水平分别为43.15±14.29、51.91±16.99、193.4±35.37、198.0 + 29.73和185.7±43.21 μg/ml。诊断SAP诱发的ARDS的血清SP-A水平的最佳临界值为150 μg/ml,SP-A的ROC曲线下面积为0.88。SP-A诊断SAP诱发的ARDS的敏感性、特异性、阳性预测值、阴性预测值和准确性分别为100.0%﹑81.8%﹑71.4%﹑100.0%和87.5%。
血清SP-A水平可能有助于检测SAP诱发的ARDS,并有助于支持ARDS的临床诊断。区分SAP诱发的ARDS与其他组(SO组和非ARDS组)的最佳血清SP-A临界值约为150 μg/ml。